LITTLE GREEN PHARMA LTD(LGP.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

LGP.AU LITTLE GREEN PHARMA LTD

Market Closed 05-17 16:12:00 AEST

0.13

+0.00

-3.85%

High0.13	Low0.13	Vol16.03K
Open0.13	D1 Closing0.13	Amplitude3.85%
Mkt Cap37.69M	Tradable Cap20.19M	Total Shares301.55M
T/O2.00K	T/O Rate0.01%	Tradable Shares161.51M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LGP.AU","market":"AU","secType":"STK","nameCN":"LITTLE GREEN PHARMA LTD","latestPrice":0.125,"timestamp":1715926320000,"preClose":0.13,"halted":0,"volume":16032,"delay":0,"nameEN":"LITTLE GREEN PHARMA LTD","floatShares":161512886,"shares":301550606,"eps":-0.012763,"marketStatus":"Market Closed","change":-0.005,"latestTime":"05-17 16:12:00 AEST","open":0.125,"high":0.13,"low":0.125,"amount":2004,"amplitude":0.038462,"askPrice":0.13,"askSize":127750,"bidPrice":0.125,"bidSize":155566,"shortable":3,"etf":0,"ttmEps":-0.012763,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1716163200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.13,"openAndCloseTimeList":[[1715904000000,1715925600000]],"volumeRatio":0.16446146856995955,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/LGP.AU/tweets","defaultTab":"tweets","newsList":[{"id":"2432661986","title":"Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger","url":"https://stock-news.laohu8.com/highlight/detail?id=2432661986","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2432661986?lang=en_us&edition=fundamental","pubTime":"2024-05-02 08:06","pubTimestamp":1714608360,"startTime":"0","endTime":"0","summary":"Overnight, the Democratic Biden government did something sure to give their counterparts counterpoints – the USA downgraded the risk profile it gives cannabis.Cannabis, or marijuana, is now a ‘schedule 3’ drug in the US, which caused a run up in the stock prices of some US cannabis stocks – at least one ETF jumped some 25%.ASX-listed Little Green Pharma  has also released news on the move today – not too long after Germany made weed legal wholemeal.The US Drugs Enforcement Agency  will ultimately oversee the changes to America’s justice system where related to cannabis charges.The implication the market is hearing is – perhaps predictably – that this will translate into less regulation and control over medicinal cannabis products.LGP did note on Thursday however that the US Department of Health and Human Services had suggested the DEA wind back the intensity of its anti-cannabis stance back in 2023.It’s also an election year, and the Democrats are scrambling to secure young voters – pa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/little-green-pharma-closely-eyeing-usas-legal-downgrade-of-cannabis-danger-2024-05-02/","is_publish_highlight":false,"gpt_icon":0},{"id":"2432561763","title":"Could ASX cannabis shares be set for a smoking hot rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2432561763","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2432561763?lang=en_us&edition=fundamental","pubTime":"2024-05-01 09:43","pubTimestamp":1714527784,"startTime":"0","endTime":"0","summary":"Moving cannabis to a less onerous drug classification would lower taxes on pot stocks and could also encourage more US states to legalise it, offering a growing legal market. It would also help cannabis companies in the US to access banking services. Dan Ahrens, managing director of Advisorshares Investments said , \"There's been a lot of rumours coming out in the last few days, but this looks official…I think it makes it easier for the House and Senate to act on SAFER Banking.\" And, as Jefferies analystOwen Bennettnotes, a reclassification by the DEA could see more institutional investment flow into the sector. While that would likely be more beneficial to American listed stocks, ASX cannabis shares could enjoy some welcome tailwinds from this shift. \"The major reason current multiples are depressed is lack of institutional ownership,\" Bennett said. He added that the DEA's move:  Would hugely improve the prospects of full federal legalisation within the next five years, with a cr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/05/01/could-asx-cannabis-shares-be-set-for-a-smoking-hot-rebound/","is_publish_highlight":false,"gpt_icon":0},{"id":"2431885688","title":"Little Green Pharma continues to shine in a paddock of pot stock weeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2431885688","media":"Informed Investor","top":-1,"share":"https://ttm.financial/m/news/2431885688?lang=en_us&edition=fundamental","pubTime":"2024-04-29 10:23","pubTimestamp":1714357382,"startTime":"0","endTime":"0","summary":"The uptake of medicinal cannabis products in Australia continues to boom, but most providers of the herbaceous material are not reaping the benefits because of oversupply, commoditised pricing and investor indifference.","market":null,"thumbnail":"https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/debb6629f87bac85f19375a1181d8e4868ac47d0.jpg","type":0,"news_type":0,"thumbnails":["https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/debb6629f87bac85f19375a1181d8e4868ac47d0.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.sharecafe.com.au/2024/04/29/little-green-pharma-continues-to-shine-in-a-paddock-of-pot-stock-weeds/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428462509","title":"A good trip? Psychedelics and the future of mental health","url":"https://stock-news.laohu8.com/highlight/detail?id=2428462509","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2428462509?lang=en_us&edition=fundamental","pubTime":"2024-04-18 13:48","pubTimestamp":1713419280,"startTime":"0","endTime":"0","summary":"When psychologist Timothy Leary advised Americans to ‘turn on, tune in, drop out’ in 1966, he was thinking of psychedelic drugs – in this case, LSD – mainly in terms of its recreational use.Now there’s an emerging body of research suggesting the true value of psychedelics might be found in treating psychiatric conditions such as post-traumatic stress disorder  and persistent depression.Moreover, a flurry of recent announcements in the pharmaceutical industry space, has pointed to the possibility of Australia leading the way when it comes to innovation here. But how efficacious might these drugs be?In January, Little Green Pharma  announced that its psychedelic-focused subsidiary Reset Mind Sciences had kicked off its own trial into the clinical use of psilocybin  to treat depression, with this being conducted through the Harry Perkins Institute and Fiona Stanley Hospital, both in Perth.Emyria managing director Mike Winlo said the twin factors of changing government perspective and phar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/a-good-trip-psychedelics-and-the-future-of-mental-health-2024-04-18/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428542833","title":"Market Update: Brighter ASX surfaces with a smile","url":"https://stock-news.laohu8.com/highlight/detail?id=2428542833","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2428542833?lang=en_us&edition=fundamental","pubTime":"2024-04-17 12:11","pubTimestamp":1713327060,"startTime":"0","endTime":"0","summary":"The ASX200 is up around a quarter of a per cent – beating futures predictions by about half a per cent.Utilities is up around 1.9 per cent – whilst energy and materials are falling off the pace.Melbourne-based pharmaceutical developer Firebrick Pharma Limited  Share Price | Latest News – The Market Online is up 53 per cent after confirming its Nasodine nasal spray is being launched in the US today.Bank Of Queensland Limited.  Share Price | Latest News – The Market Onlineis up around 7 per cent despite releasing itshalf yearly resultsto the end of February and seeing its net profit after tax downby 33 percenton the same period in 2023 to $172 million.Cancer-focused company Immutep Limited  Share Price | Latest News – The Market Online is down more than 3 per cent despite receiving positive feedback from the Spanish Agency for Medicines and Health Products to proceed to the third phase of trials for “eftilagimod alpha” – a drug that treats a spreadable deadly type of lung cancer.Little G","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/market-update-brighter-asx-surfaces-with-a-smile-2024-04-17/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428332341","title":"Little Green Pharma heading into Q2 cashed up after record sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2428332341","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2428332341?lang=en_us&edition=fundamental","pubTime":"2024-04-17 09:57","pubTimestamp":1713319020,"startTime":"0","endTime":"0","summary":"Little Green Pharma  wound up Q1CY24 with $5M in cash after posting record cash receipts of $8.1M, up 53% QoQ.On a year-on-year basis, cash receipts were up 21% “driven by the collection overdue receivables” as well as outright sales increases.Unaudited, the revenue metric marks a record quarter for LGP – the company posted $7.3M in revenue , up 34% QoQ and 36% YoY.The first three months of CY24 have officially been LGP’s best quarter yet to date.Heading into the final quarter of the financial year, FY24 has seen LGP rake in $25.6M in revenue on an unaudited basis, another record for the stock, up 30% vs. FY23.That trend may continue with LGP moving into Poland and Switzerland in the quarter – and staying with the EU, cannabis was also legalised in Germany during the quarter, which LGP expects to provide strong revenue generation potential.Meanwhile, Reset Mind Sciences , LGP’s psychedelics research spin-out hopeful, continues to stay on the company’s radar, despite being knocked back ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/little-green-pharma-heading-into-q2-cashed-up-after-record-sales-2024-04-17/","is_publish_highlight":false,"gpt_icon":0},{"id":"2428076336","title":"BRIEF-Little Green Pharma Posts Qtrly Revenue Of A$7.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2428076336","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2428076336?lang=en_us&edition=fundamental","pubTime":"2024-04-17 09:24","pubTimestamp":1713317072,"startTime":"0","endTime":"0","summary":"April 17 (Reuters) - Little Green Pharma Ltd   :   * QUARTERLY REVENUE OF A$7.3 MILLION, UP 34%Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424362816","title":"ADVISORY-Alert on earnings estimate incorrectly tagged to Little Green Pharma withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2424362816","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2424362816?lang=en_us&edition=fundamental","pubTime":"2024-04-03 19:23","pubTimestamp":1712143414,"startTime":"0","endTime":"0","summary":"An alert on Signet Jewelers'    FY25 earnings per share estimate was incorrectly tagged to Australia-based medicinal cannabis company Little Green Pharma    and has been withdrawn.   There will be no substitute.    STORY_NUMBER: nFWN3GC0G0 STORY_DATE: 03/04/2024 STORY_TIME: 10:50:37 AM GMT","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424155108","title":"SIGNET JEWELERS REPURCHASES 50% OF CONVERTIBLE PREFERRED SHARES AHEAD OF MATURITY","url":"https://stock-news.laohu8.com/highlight/detail?id=2424155108","media":"PR Newswire","top":-1,"share":"https://ttm.financial/m/news/2424155108?lang=en_us&edition=fundamental","pubTime":"2024-04-03 18:50","pubTimestamp":1712141400,"startTime":"0","endTime":"0","summary":"Net Share Settlement Amendment Further Reduces Diluted Share Count Increases FY2025 Non-GAAP EPS Guidance by 9% to 10%. HAMILTON, Bermuda, April 3, 2024 /PRNewswire/ -- Signet Jewelers Limited  , the world's largest retailer of diamond jewelry, and Leonard Green & Partners, L.P. , a leading private equity investment firm, today announced the amendment of the terms of the Series A Convertible Preference Shares  to net share settlement and the repurchase of half of the Preferred Shares.\"LGP has been a strong supporter of Signet through our transformation journey from the time of our agreement in 2016 and throughout the execution of our Path to Brilliance strategy. Since launching this strategy, Signet has grown revenue double digits while optimizing our fleet, increased gross margins by more than 400 basis points, drove a nearly 60% increase to our non-GAAP diluted earnings per share, and returned more than $1.5 billion to shareholders while investing for future competitive advantage. Si","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gas9MZ3mUpgpekUwYtH4wQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/93a23697c6f5ce4990c7c9990516996b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gas9MZ3mUpgpekUwYtH4wQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/93a23697c6f5ce4990c7c9990516996b"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/signet-jewelers-repurchases-50-convertible-105000374.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/signet-jewelers-repurchases-50-convertible-105000374.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2423467240","title":"Home Depot Acquires SRS For 6 Times What It Fetched In 2018 - Cause For Concern?","url":"https://stock-news.laohu8.com/highlight/detail?id=2423467240","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2423467240?lang=en_us&edition=fundamental","pubTime":"2024-03-29 22:00","pubTimestamp":1711720856,"startTime":"0","endTime":"0","summary":"The Home Depot yesterday announced it will acquire SRS Distribution in a $18.3 billion transaction - $15 billion more than what the business fetched only six years ago.In this update, I share my views","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4681234-home-depot-acquires-srs-for-six-times-what-it-fetched-in-2018-cause-for-concern","is_publish_highlight":false,"gpt_icon":0},{"id":"2417473376","title":"Little Green Pharma (ASX:LGP) Has Debt But No Earnings; Should You Worry?","url":"https://stock-news.laohu8.com/highlight/detail?id=2417473376","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2417473376?lang=en_us&edition=fundamental","pubTime":"2024-03-06 04:13","pubTimestamp":1709669587,"startTime":"0","endTime":"0","summary":"Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-lgp/little-green-pharma-shares/news/little-green-pharma-asxlgp-has-debt-but-no-earnings-should-y","is_publish_highlight":false,"gpt_icon":0},{"id":"2416463683","title":"Going concerns notices raised for ASX cannabis players Cann Group and Althea","url":"https://stock-news.laohu8.com/highlight/detail?id=2416463683","media":"Business News Australia","top":-1,"share":"https://ttm.financial/m/news/2416463683?lang=en_us&edition=fundamental","pubTime":"2024-03-01 00:00","pubTimestamp":1709222400,"startTime":"0","endTime":"0","summary":"Material uncertainties have been raised about two of the largest&nb...","market":null,"thumbnail":"https://assets.cdn.thewebconsole.com/S3WEB6082/a_images/65e115b91989f.jpg?v=2&m=b7974e992e277ad495f919c705196df6&lqip(10)","type":0,"news_type":0,"thumbnails":["https://assets.cdn.thewebconsole.com/S3WEB6082/a_images/65e115b91989f.jpg?v=2&m=b7974e992e277ad495f919c705196df6&lqip(10)"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.businessnewsaustralia.com/articles/going-concerns-notices-raised-for-asx-cannabis-players-cann-group-and-althea.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2414128366","title":"Market Update: ASX200 flat as inflation holds at two-year low","url":"https://stock-news.laohu8.com/highlight/detail?id=2414128366","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2414128366?lang=en_us&edition=fundamental","pubTime":"2024-02-28 12:10","pubTimestamp":1709093400,"startTime":"0","endTime":"0","summary":"The IT sector has surged, up more than 2 per cent, while telecommunications is struggling, shedding about a per cent.The Australian Bureau of Statistics  reported a 3.4 per cent rise in inflation for the year to January 2024, continuing the trend of the lowest annual rate since November 2021.Now, in this mid-session update, we’ll discuss Neuren Pharmaceuticals, Orcoda, Augustus Minerals, and Little Green Pharma.One of the top-trending stories on HotCopper is Neuren Pharmaceuticals . The company posted strong Q4 2023 sales of its flagship drug DAYBUE to US$87.1 million.Despite this, Neuren shares have slumped 12 per cent.This could be linked to a recent incident where Neuren shares plunged following a report from US short-selling firm Culper Research, accusing Neuren partner Acadia of dishonest reporting.Integrated technology company Orcoda  has welcomed Maree Adshead as an independent Non-Executive Director.Augustus Minerals  geotechnical teams are set to begin fieldwork at its Ti-Tree","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/market-update-asx200-flat-as-inflation-holds-at-two-year-low-2024-02-28/","is_publish_highlight":false,"gpt_icon":0},{"id":"2414446043","title":"Little Green Pharma shares surge as Germany legalises Cannabis","url":"https://stock-news.laohu8.com/highlight/detail?id=2414446043","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2414446043?lang=en_us&edition=fundamental","pubTime":"2024-02-26 09:45","pubTimestamp":1708911900,"startTime":"0","endTime":"0","summary":"Little Green Pharma  reveals a groundbreaking development with the German Bundestag’s decision on Friday to legalise cannabis, removing it from the Narcotics List starting April 1, 2024. Comparable to Canada’s cannabis legalisation in 2018, positioning Germany as the largest federally legal cannabis market globally. The legislative shift allows for the creation of not-for-profit cannabis clubs, limited home cultivation, and personal use possession. The move presents an opportunity for LGP, to leverage its established partnerships with multiple German distributors. This marks a significant move, comparable to Canada’s cannabis legalisation in 2018, positioning Germany as the largest federally legal cannabis market globally.As Europe’s  primary medicinal cannabis market, Germany is anticipated to witness an increase in patients and consumers, paving the way for similar changes across the continent.The move presents an opportunity for LGP, to leverage its established partnerships with mul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/little-green-pharma-shares-surge-as-germany-legalises-cannabis-2024-02-26/","is_publish_highlight":false,"gpt_icon":0},{"id":"2414046274","title":"Little Green Pharma upbeat on Germany's legalisation of cannabis","url":"https://stock-news.laohu8.com/highlight/detail?id=2414046274","media":"Business News Australia","top":-1,"share":"https://ttm.financial/m/news/2414046274?lang=en_us&edition=fundamental","pubTime":"2024-02-26 00:00","pubTimestamp":1708876800,"startTime":"0","endTime":"0","summary":"Perth-headquartered medicinal cannabis company Little Green Pharma ...","market":null,"thumbnail":"https://assets.cdn.thewebconsole.com/S3WEB6082/a_images/65dbdf858be79.jpg?v=2&m=cb9544fefde351994409785ba8f0b987&lqip(10)","type":0,"news_type":0,"thumbnails":["https://assets.cdn.thewebconsole.com/S3WEB6082/a_images/65dbdf858be79.jpg?v=2&m=cb9544fefde351994409785ba8f0b987&lqip(10)"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.businessnewsaustralia.com/articles/little-green-pharma-upbeat-on-germany-s-legalisation-of-cannabis.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2412978524","title":"Market Update: ASX200 flat, Seven Group eyes Boral, Westpac up despite profit fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2412978524","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2412978524?lang=en_us&edition=fundamental","pubTime":"2024-02-19 13:07","pubTimestamp":1708319220,"startTime":"0","endTime":"0","summary":"The ASX200 has been trading quite flat this morning, but a couple of sectors have taken a hit.Real estate has been down nearly three per cent and IT by nearly 1.2 per cent – indeed the all-technology index took a fall in early trade, losing about 0.65 per cent.Shares in APM Human Services International – which has former WA premier Mark McGowan and other big names on its advisory board – surged more than 50 per cent this morning due to an acquisition approach by CVC Asia Pacific.Westpac  has been trading up 2.4 per cent despite its December update revealing a six per cent decline in unaudited net profit to around $1.5 billion. The bank blames hedge accounting items that it reports will reverse in time.The A2 Milk Company  is up 16 per cent on half-yearly results showing 3.7 per cent revenue growth and five per cent EBITDA growth. Shares have been trading at $5.87.Little Green Pharma  has withdrawn offers under a Prospectus to separate its subsidiary Reset Mind Sciences. UK funds were b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/market-update-asx200-flat-seven-group-eyes-boral-westpac-up-despite-profit-fall-2024-02-19/","is_publish_highlight":false,"gpt_icon":0},{"id":"2412947638","title":"Reset Mind Sciences to remain Little Green Pharma subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2412947638","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2412947638?lang=en_us&edition=fundamental","pubTime":"2024-02-19 10:11","pubTimestamp":1708308660,"startTime":"0","endTime":"0","summary":"Reset withdraws its offers under the Prospectus lodged with ASIC on November 9, 2023, and will remain a subsidiary of Little Green Pharma . The withdrawal follows from the AIM stock exchange’s decision that PAP is currently not allowed in the United Kingdom. Despite this setback, the company maintains an optimistic outlook on the global progress of psychedelics and anticipates the legalisation of PAP services in the UK in the near future. The decision follows a ruling by the AIM stock exchange that psychedelic-assisted psychotherapy  is currently not permitted in the United Kingdom. This prevents UK funds from investing and postpones Reset’s ability to list on a UK exchange.At that point, Reset intends to resume engagement with regulators.In the interim, Little Green Pharma will continue to advance its prominent position in the global psychedelics industry.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/reset-mind-sciences-to-remain-little-green-pharma-subsidiary-2024-02-19/","is_publish_highlight":false,"gpt_icon":0},{"id":"2412947043","title":"BRIEF-Little Green Pharma Withdraws Offers Under Reset Prospectus Lodged With ASIC On 9 Nov","url":"https://stock-news.laohu8.com/highlight/detail?id=2412947043","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2412947043?lang=en_us&edition=fundamental","pubTime":"2024-02-19 09:23","pubTimestamp":1708305830,"startTime":"0","endTime":"0","summary":"Feb 19 (Reuters) - Little Green Pharma Ltd   :   * WITHDRAWN ITS OFFERS UNDER RESET PROSPECTUS LODGED WITH ASIC ON 9 NOV   * WILL CONTINUE TO PROGRESS ITS GLOBALLY LEADING PSYCHEDELICS BUSINESSSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408529269","title":"TMH Market Update: US Fed hawkishness sends ASX200 lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2408529269","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2408529269?lang=en_us&edition=fundamental","pubTime":"2024-02-01 13:08","pubTimestamp":1706764080,"startTime":"0","endTime":"0","summary":"The ASX200 has dropped as expected, down 1.1 per cent mid-session.Every sector is in the red, with real estate and financials both down 1.6 per cent.The Australian market performance comes after the US Federal Reserve chief Jerome Powell delivered hawkish words after keeping rates on hold overnight, suggesting the predicted March rate cut was unlikely.In this bulletin, we’ll discuss Hazer Group, Oncosil Medical, Magnum Mining and Exploration and Little Green Pharma.Cleantech developer Hazer Group is up about 12.5 per cent on achieving first hydrogen and graphite production at its commercial demonstration plant in Western Australia.Hazer plans to progressively scale up these operations.Australian medical device company, Oncosil Medical  is up nearly 15 per cent because the German Institute for the Hospital Remuneration System  is allowing 84 hospitals to negotiate with the country’s innovation funding program for access to Oncosil’s specialised device.Magnum Mining and Exploration  plan","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketherald.com.au/tmh-market-update-fed-hawkishness-sends-asx200-lower-2024-02-01/","is_publish_highlight":false,"gpt_icon":0},{"id":"2408122785","title":"Little Green Pharma receives $5m R&D rebate","url":"https://stock-news.laohu8.com/highlight/detail?id=2408122785","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2408122785?lang=en_us&edition=fundamental","pubTime":"2024-02-01 09:26","pubTimestamp":1706750760,"startTime":"0","endTime":"0","summary":"Little Green Pharma  receives a $5 million R&D rebate, its largest to date. It reflects the significant R&D expenditure invested in its multifaceted program during FY2023. The rebate is in addition to the $360,000 R&D rebate received by subsidiary Rest Mind Sciences in the December quarter. Little Green Pharma  has received a $5 million research and development (R&D) rebate, its largest to date.The company reported it reflects the significant R&D expenditure invested in its multifaceted program during FY2023.LGP had previously factored in the rebate with its financer, Radium Capital, leaving a balance of $2.8 million. This is in addition to the $360,000 R&D rebate received by subsidiary Rest Mind Sciences in the December quarter.The multifaceted program includes developing one of the largest genetic ranges of LGP’s flower products in the Australian and EU markets.LGP also sponsored the successful QUEST study, which covered the largest worldwide quality-of-life study on medicinal cannab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketherald.com.au/little-green-pharma-receives-5m-rd-rebate-2024-02-01/","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.littlegreenpharma.com","stockEarnings":[{"period":"1week","weight":-0.0385},{"period":"1month","weight":-0.0741},{"period":"3month","weight":-0.0741},{"period":"6month","weight":-0.0385},{"period":"1year","weight":-0.3056},{"period":"ytd","weight":-0.1071}],"compareEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":0.0587},{"period":"3month","weight":0.0966},{"period":"6month","weight":0.1366},{"period":"1year","weight":0.1436},{"period":"ytd","weight":0.1212}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Little Green Pharma Ltd engages in the research and development, cultivation, production, manufacturing, and distribution of medicinal cannabis products in Australia and internationally. It offers a range of medical cannabis preparations in oil formulation under the LGP Natural and LGP Advanced names. The company was founded in 2016 and is headquartered in West Perth, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.013935},{"month":2,"riseRate":0.6,"avgChangeRate":-0.019895},{"month":3,"riseRate":0,"avgChangeRate":-0.077745},{"month":4,"riseRate":0.6,"avgChangeRate":0.073049},{"month":5,"riseRate":0.25,"avgChangeRate":-0.100157},{"month":6,"riseRate":0.75,"avgChangeRate":0.1167},{"month":7,"riseRate":0,"avgChangeRate":-0.091202},{"month":8,"riseRate":0,"avgChangeRate":-0.070611},{"month":9,"riseRate":0.25,"avgChangeRate":0.033939},{"month":10,"riseRate":0.25,"avgChangeRate":0.013266},{"month":11,"riseRate":0.5,"avgChangeRate":0.02541},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012116}],"exchange":"ASX","name":"LITTLE GREEN PHARMA LTD","nameEN":"LITTLE GREEN PHARMA LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LITTLE GREEN PHARMA LTD(LGP.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LITTLE GREEN PHARMA LTD(LGP.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LITTLE GREEN PHARMA LTD,LGP.AU,LITTLE GREEN PHARMA LTD股票,LITTLE GREEN PHARMA LTD股票老虎,LITTLE GREEN PHARMA LTD股票老虎国际,LITTLE GREEN PHARMA LTD行情,LITTLE GREEN PHARMA LTD股票行情,LITTLE GREEN PHARMA LTD股价,LITTLE GREEN PHARMA LTD股市,LITTLE GREEN PHARMA LTD股票价格,LITTLE GREEN PHARMA LTD股票交易,LITTLE GREEN PHARMA LTD股票购买,LITTLE GREEN PHARMA LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LITTLE GREEN PHARMA LTD(LGP.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LITTLE GREEN PHARMA LTD(LGP.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction